HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Business Round-Up: BioGaia Held Back By COVID, Nutrinovate Acquires Vitamin Sprays, Labomar Goes Public

Executive Summary

Latest EU business news: Sweden's BioGaia warns sales to slump due to COVID-19; Nutrinovate acquires vitamin sprays firm A to K; and Italy's Labomar prepares for M&A following IPO.

You may also be interested in...



EU Probiotics News: Strong Year For Probi, BioGaia Struggles, Kerry Targets Biosearch Deal

Latest European Probiotics News: Probi and BioGaia post earnings, with differing results, while Kerry seeks to expand with Spain's Biosearch.

BioGaia Gets Private Equity Backing To Fuel Growth

Probiotics specialist BioGaia will draw on the experience of its new private equity investor EQT as it looks to expand through acquisitions and increased digitization.

Acquisitions Help Drive Up Sales At Switzerland's Galenica In 2021

Galenica's Swiss consumer health business Verfora saw sales jump by a fifth in 2021 thanks to key acquisitions. Without the impact of these deals, Verfora's sales over the 12 months would have declined due to the negative impact of the pandemic on its business.

Topics

UsernamePublicRestriction

Register

RS150567

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel